Cargando…
Self‐resolving bullous pemphigoid induced by cemiplimab
Autores principales: | Molle, Mattia Fabio, Capurro, Niccolò, Herzum, Astrid, Micalizzi, Claudia, Cozzani, Emanuele, Parodi, Aurora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285614/ https://www.ncbi.nlm.nih.gov/pubmed/35320611 http://dx.doi.org/10.1111/dth.15466 |
Ejemplares similares
-
Guselkumab‐associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature
por: Burlando, Martina, et al.
Publicado: (2021) -
Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone
por: Viglizzo, Gianmaria, et al.
Publicado: (2022) -
Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?
por: Russo, Roberto, et al.
Publicado: (2022) -
Lichen planus flare following COVID‐19 vaccination: A case report
por: Herzum, Astrid, et al.
Publicado: (2021) -
Dermatoscopically narrowed surgical margins for head and neck basal cell carcinoma: A retrospective case‐control study
por: Herzum, Astrid, et al.
Publicado: (2022)